mouse insulin elisa kit Search Results


96
Elabscience Biotechnology elisa
Elisa, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+INS+(Insulin)+ELISA+Kit/pm38880863-235-21-23
Average 96 stars, based on 1 article reviews
elisa - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Cusabio mouse insulin elisa kit
Mouse Insulin Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+Insulin%2CINS+ELISA+Kit/pmc04663339-62-14-18
Average 95 stars, based on 1 article reviews
mouse insulin elisa kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
Proteintech antibodies against igf 1
Antibodies Against Igf 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse%2FRat+IGF1+ELISA+Kit/pmc06006361-72-35-38
Average 94 stars, based on 1 article reviews
antibodies against igf 1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
ABclonal Biotechnology mouse insulin elisa kit abclonal cat
Mouse Insulin Elisa Kit Abclonal Cat, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+Insulin+ELISA+Kit/pm34433035-223-128-132
Average 93 stars, based on 1 article reviews
mouse insulin elisa kit abclonal cat - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Cusabio gastric inhibitory peptide
Serum concentrations of ( A ) gastrin (GAS), ( B ) peptide YY (PYY), ( C ) gastric <t>inhibitory</t> peptide (GIP) were measured. Data are presented mean ± SD. Different letters indicate significant differences ( p < 0.05). NOR, normal group; CONT, loperamide injected group; MOS, mosapride-treated group; HP7-L, low-dose heat-killed HP7 treated group (10 8 CFU kg/day); HP7-H, high-dose heat-killed HP7 treated group (10 9 CFU/kg/day).
Gastric Inhibitory Peptide, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+Glucose-dependent+insulin-releasing+polypeptide%2CGIP+ELISA+Kit/pmc12603371-53-14-12
Average 93 stars, based on 1 article reviews
gastric inhibitory peptide - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

92
Cusabio igfbp2
ICA-CUR inhibits the <t>DNMT1/IGFBP2</t> pathway and activates the cytotoxic effect of CD8 + T cell. A The levels of IGFBP2 in serum were tested via ELISA. B The levels of DNMT1 and IGFBP2 in tumor tissues were tested via IHC (Magnification: ×100, scale bar = 100 μm; Magnification: ×400, scale bar = 25 μm). C The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. D The protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues were detected by WB. E FCM was used to test the infiltration of CD8 + T cells (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells). F The levels of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues were detected by RT-PCR. G The levels of IFN-γ and IFN-α in serum were tested via ELISA. * P < 0.05 vs. PCa
Igfbp2, supplied by Cusabio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+Insulin-like+growth+factor+binding+protein+2%2CIGFBP-2+ELISA+KIT/pmc11112810-160-12-14
Average 92 stars, based on 1 article reviews
igfbp2 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

93
ABclonal Biotechnology mouse igf 1
ICA-CUR inhibits the <t>DNMT1/IGFBP2</t> pathway and activates the cytotoxic effect of CD8 + T cell. A The levels of IGFBP2 in serum were tested via ELISA. B The levels of DNMT1 and IGFBP2 in tumor tissues were tested via IHC (Magnification: ×100, scale bar = 100 μm; Magnification: ×400, scale bar = 25 μm). C The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. D The protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues were detected by WB. E FCM was used to test the infiltration of CD8 + T cells (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells). F The levels of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues were detected by RT-PCR. G The levels of IFN-γ and IFN-α in serum were tested via ELISA. * P < 0.05 vs. PCa
Mouse Igf 1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+Insulin+Like+Growth+Factor+1+ELISA+Kit/pmc10168008-87-14-16
Average 93 stars, based on 1 article reviews
mouse igf 1 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Elabscience Biotechnology igfbp2
ICA-CUR inhibits the <t>DNMT1/IGFBP2</t> pathway and activates the cytotoxic effect of CD8 + T cell. A The levels of IGFBP2 in serum were tested via ELISA. B The levels of DNMT1 and IGFBP2 in tumor tissues were tested via IHC (Magnification: ×100, scale bar = 100 μm; Magnification: ×400, scale bar = 25 μm). C The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. D The protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues were detected by WB. E FCM was used to test the infiltration of CD8 + T cells (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells). F The levels of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues were detected by RT-PCR. G The levels of IFN-γ and IFN-α in serum were tested via ELISA. * P < 0.05 vs. PCa
Igfbp2, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+IGFBP-2+(Insulin-like+Growth+Factor+Binding+Protein+2)+ELISA+Kit/pmc12147179-340-8-13
Average 93 stars, based on 1 article reviews
igfbp2 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Cusabio mouse insulin like growth factor 1 igf 1 elisa kit
ICA-CUR inhibits the <t>DNMT1/IGFBP2</t> pathway and activates the cytotoxic effect of CD8 + T cell. A The levels of IGFBP2 in serum were tested via ELISA. B The levels of DNMT1 and IGFBP2 in tumor tissues were tested via IHC (Magnification: ×100, scale bar = 100 μm; Magnification: ×400, scale bar = 25 μm). C The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. D The protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues were detected by WB. E FCM was used to test the infiltration of CD8 + T cells (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells). F The levels of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues were detected by RT-PCR. G The levels of IFN-γ and IFN-α in serum were tested via ELISA. * P < 0.05 vs. PCa
Mouse Insulin Like Growth Factor 1 Igf 1 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+Insulin-like+growth+factor+1%2CIGF-1+ELISA+Kit/pmc10568430-35-0-9
Average 90 stars, based on 1 article reviews
mouse insulin like growth factor 1 igf 1 elisa kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
ABclonal Biotechnology mouse igfbp4
Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the <t>AAC2-IGFBP4</t> complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)
Mouse Igfbp4, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+Insulin+Like+Growth+Factor+Binding+Protein+4+ELISA+Kit/pmc12853802-307-8-11
Average 93 stars, based on 1 article reviews
mouse igfbp4 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

91
Novus Biologicals insulin nbp2 62853
Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the <t>AAC2-IGFBP4</t> complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)
Insulin Nbp2 62853, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+Insulin+ELISA+Kit+(Colorimetric)/pm37293506-58-2-2
Average 91 stars, based on 1 article reviews
insulin nbp2 62853 - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

93
Elabscience Biotechnology elisa kit
A , B “U” and inverted “U” shaped relationship between IGF2 levels and the lipid species detected by LC-MS/MS assay utilizing a polynomial fourth order equation to fit the non-linear regression curve, where R² (R-squared) represents the coefficient of determination, and Sy.x represents the standard deviation of the residuals, n = 200. C , D “U” and inverted “U” shaped relationship between IGF2 levels and the lipid species detected by <t>ELISA</t> <t>kit</t> assay utilizing a polynomial fourth order equation to fit the non-linear regression curve, n = 200. E , F Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with triglyceride conducted by LC-MS/MS assay, n = 200, all p < 0.01. G , H Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with HDL-c conducted by LC-MS/MS assay, n = 200, all p < 0.05. I , J Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with triglyceride conducted by ELISA kit assay, n = 200, all p < 0.001. K , L Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with HDL-c conducted by ELISA kit assay, n = 200, all p < 0.05. M , N Multiple stepwise logistic regression analysis of MetS, HOMA-IR, and other metabolic subgroups (central obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low HDL-c) connected with L-IGF2 and H-IGF2 levels conducted by LC-MS/MS assay and ELISA kit assay, respectively.
Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+elisa+kit/Mouse+IGF-1+(Insulin-like+Growth+Factor+1)+ELISA+Kit/pmc12241405-431-11-14
Average 93 stars, based on 1 article reviews
elisa kit - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


Serum concentrations of ( A ) gastrin (GAS), ( B ) peptide YY (PYY), ( C ) gastric inhibitory peptide (GIP) were measured. Data are presented mean ± SD. Different letters indicate significant differences ( p < 0.05). NOR, normal group; CONT, loperamide injected group; MOS, mosapride-treated group; HP7-L, low-dose heat-killed HP7 treated group (10 8 CFU kg/day); HP7-H, high-dose heat-killed HP7 treated group (10 9 CFU/kg/day).

Journal: Journal of Microbiology and Biotechnology

Article Title: Postbiotic Potential of Heat-Killed Lacticaseibacillus paracasei HP7 in Functional Dyspepsia

doi: 10.4014/jmb.2508.08029

Figure Lengend Snippet: Serum concentrations of ( A ) gastrin (GAS), ( B ) peptide YY (PYY), ( C ) gastric inhibitory peptide (GIP) were measured. Data are presented mean ± SD. Different letters indicate significant differences ( p < 0.05). NOR, normal group; CONT, loperamide injected group; MOS, mosapride-treated group; HP7-L, low-dose heat-killed HP7 treated group (10 8 CFU kg/day); HP7-H, high-dose heat-killed HP7 treated group (10 9 CFU/kg/day).

Article Snippet: The level of regulatory hormones such as gastrin (GAS, CSB- E12924 ; CUSABIO, USA), gastric inhibitory peptide (GIP, CSB-E08486m), and peptide YY (PYY, CSB-EL019128MO) in the serum were quantified according to the manufacturer’s instructions.

Techniques: Injection

ICA-CUR inhibits the DNMT1/IGFBP2 pathway and activates the cytotoxic effect of CD8 + T cell. A The levels of IGFBP2 in serum were tested via ELISA. B The levels of DNMT1 and IGFBP2 in tumor tissues were tested via IHC (Magnification: ×100, scale bar = 100 μm; Magnification: ×400, scale bar = 25 μm). C The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. D The protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues were detected by WB. E FCM was used to test the infiltration of CD8 + T cells (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells). F The levels of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues were detected by RT-PCR. G The levels of IFN-γ and IFN-α in serum were tested via ELISA. * P < 0.05 vs. PCa

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Icaritin-curcumol activates CD8 + T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer

doi: 10.1186/s13046-024-03063-2

Figure Lengend Snippet: ICA-CUR inhibits the DNMT1/IGFBP2 pathway and activates the cytotoxic effect of CD8 + T cell. A The levels of IGFBP2 in serum were tested via ELISA. B The levels of DNMT1 and IGFBP2 in tumor tissues were tested via IHC (Magnification: ×100, scale bar = 100 μm; Magnification: ×400, scale bar = 25 μm). C The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. D The protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues were detected by WB. E FCM was used to test the infiltration of CD8 + T cells (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells). F The levels of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues were detected by RT-PCR. G The levels of IFN-γ and IFN-α in serum were tested via ELISA. * P < 0.05 vs. PCa

Article Snippet: According to the kit’s instructions, ELISA was utilized to evaluate levels of IGFBP2 (CSB-E04589m, CUSABIO), interferon-γ (IFN-γ) (KE10001, Proteintech), interferon-α (IFN-α) (MFNAS0, R&D Systems), Perforin (Cbic-E13429m, CUSABIO), Granzyme A (CSB-E08717m, CUSABIO, China) and Granzyme B (CSB-E08720m, CUSABIO, China).

Techniques: Enzyme-linked Immunosorbent Assay, Reverse Transcription Polymerase Chain Reaction

FMT from donors in the ICA-CUR treatment inhibits the development of PCa and activates the cytotoxic effects of CD8 + T cells. A Tumor imaging, volume, and weight measurements. B IF staining was utilized to examine changes in Ki67 expression in tumors (Magnification: ×400, scale bar = 25 μm). C The levels of IGFBP2 in serum were tested via ELISA. D The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. E WB was used to detected the protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues. F The infiltration of CD8 + T cells in mouse tumor tissues (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells) was detected by FCM. G The expression of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues was detected by RT-PCR. H The levels of IFN-γ and IFN-α in serum were tested via ELISA. * P < 0.05 vs. FMT-PCa

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Icaritin-curcumol activates CD8 + T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer

doi: 10.1186/s13046-024-03063-2

Figure Lengend Snippet: FMT from donors in the ICA-CUR treatment inhibits the development of PCa and activates the cytotoxic effects of CD8 + T cells. A Tumor imaging, volume, and weight measurements. B IF staining was utilized to examine changes in Ki67 expression in tumors (Magnification: ×400, scale bar = 25 μm). C The levels of IGFBP2 in serum were tested via ELISA. D The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. E WB was used to detected the protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues. F The infiltration of CD8 + T cells in mouse tumor tissues (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells) was detected by FCM. G The expression of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues was detected by RT-PCR. H The levels of IFN-γ and IFN-α in serum were tested via ELISA. * P < 0.05 vs. FMT-PCa

Article Snippet: According to the kit’s instructions, ELISA was utilized to evaluate levels of IGFBP2 (CSB-E04589m, CUSABIO), interferon-γ (IFN-γ) (KE10001, Proteintech), interferon-α (IFN-α) (MFNAS0, R&D Systems), Perforin (Cbic-E13429m, CUSABIO), Granzyme A (CSB-E08717m, CUSABIO, China) and Granzyme B (CSB-E08720m, CUSABIO, China).

Techniques: Imaging, Staining, Expressing, Enzyme-linked Immunosorbent Assay, Reverse Transcription Polymerase Chain Reaction

ICA-CUR inhibits tumor development and activates cytotoxic effects of CD8 + T cells by suppressing the SCFAs-IGFBP2 axis. A The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. B The levels of IGFBP2 in serum were tested via ELISA. C The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. * P < 0.05 vs. ICA + CUR. D Tumor imaging, volume, and weight measurements. E IF staining to examine changes in Ki67 expression in tumors (Magnification: ×400, scale bar = 25 μm). F ELISA was used to detect the levels of IGFBP2 in serum. G The protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues were detected by WB. H The infiltration of CD8 + T cells in mouse tumor tissues (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells) was detected by FCM. I The levels of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues were detected by RT-PCR. J ELISA was utilized to detect the levels of IFN-γ and IFN-α in serum. * P < 0.05 vs. ICA + CUR + IgG, # P < 0.05 vs. ICA + CUR + anti-IGFBP2

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Icaritin-curcumol activates CD8 + T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer

doi: 10.1186/s13046-024-03063-2

Figure Lengend Snippet: ICA-CUR inhibits tumor development and activates cytotoxic effects of CD8 + T cells by suppressing the SCFAs-IGFBP2 axis. A The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. B The levels of IGFBP2 in serum were tested via ELISA. C The levels of DNMT1 and IGFBP2 in tumor tissues were detected by WB. * P < 0.05 vs. ICA + CUR. D Tumor imaging, volume, and weight measurements. E IF staining to examine changes in Ki67 expression in tumors (Magnification: ×400, scale bar = 25 μm). F ELISA was used to detect the levels of IGFBP2 in serum. G The protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3 in tumor tissues were detected by WB. H The infiltration of CD8 + T cells in mouse tumor tissues (positivity of CD3 + CD8 + IFN-γ and CD3 + CD8 + Ki67 cells) was detected by FCM. I The levels of perforin, granzyme A, and B in sorted CD8 + T cells from tumor tissues were detected by RT-PCR. J ELISA was utilized to detect the levels of IFN-γ and IFN-α in serum. * P < 0.05 vs. ICA + CUR + IgG, # P < 0.05 vs. ICA + CUR + anti-IGFBP2

Article Snippet: According to the kit’s instructions, ELISA was utilized to evaluate levels of IGFBP2 (CSB-E04589m, CUSABIO), interferon-γ (IFN-γ) (KE10001, Proteintech), interferon-α (IFN-α) (MFNAS0, R&D Systems), Perforin (Cbic-E13429m, CUSABIO), Granzyme A (CSB-E08717m, CUSABIO, China) and Granzyme B (CSB-E08720m, CUSABIO, China).

Techniques: Enzyme-linked Immunosorbent Assay, Imaging, Staining, Expressing, Reverse Transcription Polymerase Chain Reaction

ICA-CUR inhibits the development of PCa, the DNMT1/IGFBP2 pathway, and activates cytotoxic effects of CD8 + T cells in vitro. A CCK-8 was utilized to assess the proliferation ability of cells. B Transwell was applied to measure the migration and invasion ability of cells. C The level of IGFBP2 in cells was tested via ELISA. D The levels of DNMT1 and IGFBP2 in cells were detected by WB. E WB was utilized to monitor protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3. * P < 0.05 vs. Control. F FCM analysis of CD8 + IFN-γ cells. G The expression of perforin, granzyme A, and B in sorted CD8 + T cells was detected by WB. H IL-2, IFN-γ, and IFN-α levels in supernatant were measured through ELISA. I Perforin and granzyme B levels in the supernatant were tested via ELISA. & P < 0.05 vs. RM-1 + T cells

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Icaritin-curcumol activates CD8 + T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer

doi: 10.1186/s13046-024-03063-2

Figure Lengend Snippet: ICA-CUR inhibits the development of PCa, the DNMT1/IGFBP2 pathway, and activates cytotoxic effects of CD8 + T cells in vitro. A CCK-8 was utilized to assess the proliferation ability of cells. B Transwell was applied to measure the migration and invasion ability of cells. C The level of IGFBP2 in cells was tested via ELISA. D The levels of DNMT1 and IGFBP2 in cells were detected by WB. E WB was utilized to monitor protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3. * P < 0.05 vs. Control. F FCM analysis of CD8 + IFN-γ cells. G The expression of perforin, granzyme A, and B in sorted CD8 + T cells was detected by WB. H IL-2, IFN-γ, and IFN-α levels in supernatant were measured through ELISA. I Perforin and granzyme B levels in the supernatant were tested via ELISA. & P < 0.05 vs. RM-1 + T cells

Article Snippet: According to the kit’s instructions, ELISA was utilized to evaluate levels of IGFBP2 (CSB-E04589m, CUSABIO), interferon-γ (IFN-γ) (KE10001, Proteintech), interferon-α (IFN-α) (MFNAS0, R&D Systems), Perforin (Cbic-E13429m, CUSABIO), Granzyme A (CSB-E08717m, CUSABIO, China) and Granzyme B (CSB-E08720m, CUSABIO, China).

Techniques: In Vitro, CCK-8 Assay, Migration, Enzyme-linked Immunosorbent Assay, Control, Expressing

ICA-CUR inhibits the development of PCa and activates the cytotoxic effects of CD8 + T cells through the inhibition of the DNMT1/IGFBP2 pathway. A Transfection efficiency detection by WB. B CCK-8 was utilized to assess the proliferation ability of cells. C Cell migration and invasion ability detection by Transwell assay. D The levels of DNMT1 and IGFBP2 in cells were detected by WB. E WB was utilized to monitor protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3. F FCM analysis of CD3 + CD8 + IFN-γ cells. G The levels of perforin, granzyme A, and B in sorted CD8 + T cells were detected by RT-qPCR. H The levels of IL-2, IFN-γ, and IFN-α in serum. I perforin, granzyme A and B levels in the supernatant were tested via ELISA. * P < 0.05 vs. Control, # P < 0.05 vs. ICR + CUR + oe-NC, & P < 0.05 vs. ICR + CUR + oe-DNMT1 + si-NC

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Icaritin-curcumol activates CD8 + T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer

doi: 10.1186/s13046-024-03063-2

Figure Lengend Snippet: ICA-CUR inhibits the development of PCa and activates the cytotoxic effects of CD8 + T cells through the inhibition of the DNMT1/IGFBP2 pathway. A Transfection efficiency detection by WB. B CCK-8 was utilized to assess the proliferation ability of cells. C Cell migration and invasion ability detection by Transwell assay. D The levels of DNMT1 and IGFBP2 in cells were detected by WB. E WB was utilized to monitor protein changes of PD-L1, EGFR, STAT3, p-EGFR, and p-STAT3. F FCM analysis of CD3 + CD8 + IFN-γ cells. G The levels of perforin, granzyme A, and B in sorted CD8 + T cells were detected by RT-qPCR. H The levels of IL-2, IFN-γ, and IFN-α in serum. I perforin, granzyme A and B levels in the supernatant were tested via ELISA. * P < 0.05 vs. Control, # P < 0.05 vs. ICR + CUR + oe-NC, & P < 0.05 vs. ICR + CUR + oe-DNMT1 + si-NC

Article Snippet: According to the kit’s instructions, ELISA was utilized to evaluate levels of IGFBP2 (CSB-E04589m, CUSABIO), interferon-γ (IFN-γ) (KE10001, Proteintech), interferon-α (IFN-α) (MFNAS0, R&D Systems), Perforin (Cbic-E13429m, CUSABIO), Granzyme A (CSB-E08717m, CUSABIO, China) and Granzyme B (CSB-E08720m, CUSABIO, China).

Techniques: Inhibition, Transfection, CCK-8 Assay, Migration, Transwell Assay, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Control

Inhibiting DNMT1 could suppress PCa development and activate the cytotoxic effects of CD8 + T cells by inhibiting the IGFBP2/EGFR/STAT3/PD-L1 pathway. A Transfection efficiency detection by WB. B CCK-8 was utilized to assess the proliferation ability of cells. C Cell migration and invasion ability detection by Transwell assay. D The levels of DNMT1 and IGFBP2 were detected by WB. E , F WB was utilized to monitor protein changes of PD-L1, EGFR, STAT3, p-EGFR, p-STAT3, DNMT1, and IGFBP2. G FCM analysis of CD3 + CD8 + IFN-γ cells. H The levels of perforin, granzyme A, and B were detected by RT-PCR. I The levels of IL-2, IFN-γ, and IFN-α in serum. J Perforin, granzyme A, and B levels in the supernatant were tested via ELISA. * P < 0.05 vs. si-NC, # P < 0.05 vs. si-DNMT1 + oe-NC

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Icaritin-curcumol activates CD8 + T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer

doi: 10.1186/s13046-024-03063-2

Figure Lengend Snippet: Inhibiting DNMT1 could suppress PCa development and activate the cytotoxic effects of CD8 + T cells by inhibiting the IGFBP2/EGFR/STAT3/PD-L1 pathway. A Transfection efficiency detection by WB. B CCK-8 was utilized to assess the proliferation ability of cells. C Cell migration and invasion ability detection by Transwell assay. D The levels of DNMT1 and IGFBP2 were detected by WB. E , F WB was utilized to monitor protein changes of PD-L1, EGFR, STAT3, p-EGFR, p-STAT3, DNMT1, and IGFBP2. G FCM analysis of CD3 + CD8 + IFN-γ cells. H The levels of perforin, granzyme A, and B were detected by RT-PCR. I The levels of IL-2, IFN-γ, and IFN-α in serum. J Perforin, granzyme A, and B levels in the supernatant were tested via ELISA. * P < 0.05 vs. si-NC, # P < 0.05 vs. si-DNMT1 + oe-NC

Article Snippet: According to the kit’s instructions, ELISA was utilized to evaluate levels of IGFBP2 (CSB-E04589m, CUSABIO), interferon-γ (IFN-γ) (KE10001, Proteintech), interferon-α (IFN-α) (MFNAS0, R&D Systems), Perforin (Cbic-E13429m, CUSABIO), Granzyme A (CSB-E08717m, CUSABIO, China) and Granzyme B (CSB-E08720m, CUSABIO, China).

Techniques: Transfection, CCK-8 Assay, Migration, Transwell Assay, Reverse Transcription Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay

Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the AAC2-IGFBP4 complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)

Journal: Journal of Nanobiotechnology

Article Title: Bidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c

doi: 10.1186/s12951-025-03943-5

Figure Lengend Snippet: Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the AAC2-IGFBP4 complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)

Article Snippet: Plasma concentrations of human IGFBP4 (hIGFBP4; ab100542, Abcam), mouse IGFBP4 (RK02921, Abclonal), and mouse IGF1 (ab100695, Abcam) were measured by ELISA 30 days after the initiation of treatment.

Techniques: Electrophoresis, Derivative Assay

AAC2-hIGFBP4 complex increased the circulation time of hIGFBP4 without influencing mouse IGFBP4 and IGF-1 levels. ( a ) schematic of the experiment showing four ob/ob male mouse groups ( n = 5 per group) treated with control (veh, PBS), AAC2 (0.1 nmol/g body weight, BW), hIGFBP4 (1.79 nmol/g BW), or AAC2-hIGFBP4 (0.1 nmol/g and 1.79 nmol/g, respectively) every 48 h for 30 days. All data are shown and mean ± SEM. (b–d) plasma levels of therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test. therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test

Journal: Journal of Nanobiotechnology

Article Title: Bidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c

doi: 10.1186/s12951-025-03943-5

Figure Lengend Snippet: AAC2-hIGFBP4 complex increased the circulation time of hIGFBP4 without influencing mouse IGFBP4 and IGF-1 levels. ( a ) schematic of the experiment showing four ob/ob male mouse groups ( n = 5 per group) treated with control (veh, PBS), AAC2 (0.1 nmol/g body weight, BW), hIGFBP4 (1.79 nmol/g BW), or AAC2-hIGFBP4 (0.1 nmol/g and 1.79 nmol/g, respectively) every 48 h for 30 days. All data are shown and mean ± SEM. (b–d) plasma levels of therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test. therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test

Article Snippet: Plasma concentrations of human IGFBP4 (hIGFBP4; ab100542, Abcam), mouse IGFBP4 (RK02921, Abclonal), and mouse IGF1 (ab100695, Abcam) were measured by ELISA 30 days after the initiation of treatment.

Techniques: Control, Clinical Proteomics, Enzyme-linked Immunosorbent Assay

A , B “U” and inverted “U” shaped relationship between IGF2 levels and the lipid species detected by LC-MS/MS assay utilizing a polynomial fourth order equation to fit the non-linear regression curve, where R² (R-squared) represents the coefficient of determination, and Sy.x represents the standard deviation of the residuals, n = 200. C , D “U” and inverted “U” shaped relationship between IGF2 levels and the lipid species detected by ELISA kit assay utilizing a polynomial fourth order equation to fit the non-linear regression curve, n = 200. E , F Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with triglyceride conducted by LC-MS/MS assay, n = 200, all p < 0.01. G , H Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with HDL-c conducted by LC-MS/MS assay, n = 200, all p < 0.05. I , J Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with triglyceride conducted by ELISA kit assay, n = 200, all p < 0.001. K , L Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with HDL-c conducted by ELISA kit assay, n = 200, all p < 0.05. M , N Multiple stepwise logistic regression analysis of MetS, HOMA-IR, and other metabolic subgroups (central obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low HDL-c) connected with L-IGF2 and H-IGF2 levels conducted by LC-MS/MS assay and ELISA kit assay, respectively.

Journal: Communications Biology

Article Title: Paradoxical regulation of IGF2 in promoting lipid metabolism in adipose tissues

doi: 10.1038/s42003-025-08458-1

Figure Lengend Snippet: A , B “U” and inverted “U” shaped relationship between IGF2 levels and the lipid species detected by LC-MS/MS assay utilizing a polynomial fourth order equation to fit the non-linear regression curve, where R² (R-squared) represents the coefficient of determination, and Sy.x represents the standard deviation of the residuals, n = 200. C , D “U” and inverted “U” shaped relationship between IGF2 levels and the lipid species detected by ELISA kit assay utilizing a polynomial fourth order equation to fit the non-linear regression curve, n = 200. E , F Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with triglyceride conducted by LC-MS/MS assay, n = 200, all p < 0.01. G , H Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with HDL-c conducted by LC-MS/MS assay, n = 200, all p < 0.05. I , J Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with triglyceride conducted by ELISA kit assay, n = 200, all p < 0.001. K , L Pearson correlation analyses of L-IGF2 levels and H-IGF2 levels with HDL-c conducted by ELISA kit assay, n = 200, all p < 0.05. M , N Multiple stepwise logistic regression analysis of MetS, HOMA-IR, and other metabolic subgroups (central obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low HDL-c) connected with L-IGF2 and H-IGF2 levels conducted by LC-MS/MS assay and ELISA kit assay, respectively.

Article Snippet: The measurement of mice serum IGF1 level was conducted with an ELISA kit (E-EL-M3006, Elabscience, China).

Techniques: Liquid Chromatography with Mass Spectroscopy, Standard Deviation, Enzyme-linked Immunosorbent Assay

A The utilization of Nile red staining and Oil red O staining techniques revealed the presence of lipid droplets in 3T3-L1 adipocytes after IGF2 overexpression and knockdown treatment. B , C Quantification of cellular triglyceride (TG) content and the levels of free fatty acid (FFA) in the medium in 3T3-L1 adipocytes after IGF2 overexpression and knockdown treatment. * p < 0.05, ** p < 0.01. D , E The mRNA levels of genes associated with adipogenesis, lipogenesis, and lipolysis in 3T3-L1 cells transfected with Ad-IGF2 or IGF2-RNAi as well as the corresponding controls by RT-qPCR assays, using Ppia as internal controls, n = 6, Data represent the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001 by two-tailed, unpaired Student’s t test. F Protein expression levels of genes related to adipogenesis, lipogenesis and lipolysis in the 3T3-L1 adipocytes by western blot assays. G Mice adipose tissue has been dissected and isolated for primary adipocyte culture, and the results of 0, 4, 8 and 12 days were induced by the classic “Cocktail” induction differentiation regimen. H Primal cell supernatant was extracted during the above induction differentiation process, and IGF2 concentration was detected by ELISA kit. n = 3. I 3T3-L1 preadipocytes underwent treatment via different concentration gradients of recombinant IGF2 protein powder and induced differentiation. Oil red O staining employment demonstrated that the deposition of lipid droplets within adipocytes.

Journal: Communications Biology

Article Title: Paradoxical regulation of IGF2 in promoting lipid metabolism in adipose tissues

doi: 10.1038/s42003-025-08458-1

Figure Lengend Snippet: A The utilization of Nile red staining and Oil red O staining techniques revealed the presence of lipid droplets in 3T3-L1 adipocytes after IGF2 overexpression and knockdown treatment. B , C Quantification of cellular triglyceride (TG) content and the levels of free fatty acid (FFA) in the medium in 3T3-L1 adipocytes after IGF2 overexpression and knockdown treatment. * p < 0.05, ** p < 0.01. D , E The mRNA levels of genes associated with adipogenesis, lipogenesis, and lipolysis in 3T3-L1 cells transfected with Ad-IGF2 or IGF2-RNAi as well as the corresponding controls by RT-qPCR assays, using Ppia as internal controls, n = 6, Data represent the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001 by two-tailed, unpaired Student’s t test. F Protein expression levels of genes related to adipogenesis, lipogenesis and lipolysis in the 3T3-L1 adipocytes by western blot assays. G Mice adipose tissue has been dissected and isolated for primary adipocyte culture, and the results of 0, 4, 8 and 12 days were induced by the classic “Cocktail” induction differentiation regimen. H Primal cell supernatant was extracted during the above induction differentiation process, and IGF2 concentration was detected by ELISA kit. n = 3. I 3T3-L1 preadipocytes underwent treatment via different concentration gradients of recombinant IGF2 protein powder and induced differentiation. Oil red O staining employment demonstrated that the deposition of lipid droplets within adipocytes.

Article Snippet: The measurement of mice serum IGF1 level was conducted with an ELISA kit (E-EL-M3006, Elabscience, China).

Techniques: Staining, Over Expression, Knockdown, Transfection, Quantitative RT-PCR, Two Tailed Test, Expressing, Western Blot, Isolation, Concentration Assay, Enzyme-linked Immunosorbent Assay, Recombinant